DORADO, PR -- A couple of years ago, Kentucky-based BLU Pharmaceuticals’ president William ‘Bill’ Luster was on the lookout for a new solid dosage facility to manufacture generic pharmaceutical products as part of his company’s growth strategy.
Blu Pharmaceuticals, a certified minority-owned firm, focuses on the manufacturing and distribution of high quality generic pharmaceuticals at competitive prices.
Luster’s search for new business opportunities resulted in the purchasing of a 145,000 square foot production plant in Dorado, Puerto Rico that became available when generic pharmaceuticals firm Biovail decided to transfer its manufacturing operations to Steinbach, Canada, leaving hundreds of people unemployed.
“When I started looking at purchasing or building a manufacturing plant I looked in several areas of the mainland and internationally, such as New York, New Jersey, and Argentina and Brazil,” said Blu Caribe President Bill Luster. “When I... Read More